Draft Code of Conduct on Privacy for Mobile Health Applications

Mobile health applications have a clear potential to bring significant benefits to individual citizens and to society as a whole. Citizens can benefit from continuous and readily accessible support in monitoring, evaluating and improving their health. Society as a whole not only benefits from having a healthier population, but can also gain new knowledge and develop new services and applications on the basis of the data processed via these apps.

However, data concerning health is highly privacy sensitive. Therefore, mobile health apps must be designed in such a way that the privacy of the end users is optimally protected. Similarly, these apps have the potential to empower users, provided that: the users receive sufficient insight into the functioning of the app, and are able to assess more easily which of the many apps on the market meet their privacy concerns. This Code has been developed with these goals in mind: it provides an accessible and effective tool to ensure that mobile health apps have been properly developed, and that they can be entrusted with data concerning health in a manner that complies with European legal principles of data protection law.

Download: Draft Code of Conduct on Privacy for Mobile Health Applications (.pdf, 672 KB).

Download from eHealthNews.eu: Draft Code of Conduct on Privacy for Mobile Health Applications (.pdf, 672 KB).

The Code of Conduct on privacy for mobile health apps has now been formally submitted for comments to the Art 29 Data Protection Working Party. Once approved by this independent EU advisory group, the Code will be applied in practice: App developers will be able to voluntarily commit to follow its rules, which are based on EU data protection legislation.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...